• Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

  • Apr 25 2025
  • Length: 53 mins
  • Podcast

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Listen for free

View show details

  • Summary

  • Featuring an interview with Dr Adam M Brufsky, including the following topics:

    • Case: A woman in her early 50s with ER-positive, HER2-low de novo metastatic breast cancer (0:00)
    • Case: A woman in her late 70s with ER-positive, HER2-low metastatic breast cancer after 5 years of an adjuvant aromatase inhibitor (6:52)
    • Clinical Investigator Survey Results (10:05)

    CME information and select publications
    Show more Show less
Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available